HIP Corporation (2136.T)
JPY 1087.0
(-0.91%)
JPY 1087.0
(-0.91%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 5.66 Billion | 5.47 Billion | 5.18 Billion | 5 Billion | - |
| Cost of Revenue | 4.36 Billion | 4.16 Billion | 4.03 Billion | 4.06 Billion | - |
| Gross Profit | 1.29 Billion | 1.31 Billion | 1.15 Billion | 937.76 Million | - |
| Operating Expenses | 740.12 Million | 737.24 Million | 696.21 Million | 679.67 Million | 379.7 Million |
| Selling, General and Administrative Expenses | 131.54 Million | 110.24 Million | 88.44 Million | 82.93 Million | - |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | 608.58 Million | 18.68 Million | 138.41 Million | 279.08 Million | 379.7 Million |
| Cost and Expenses | 5.1 Billion | 4.89 Billion | 4.73 Billion | 4.74 Billion | 379.7 Million |
| Operating Income | 554.17 Million | 577.79 Million | 453.8 Million | 258.08 Million | 379.7 Million |
| Interest Expense | 3.94 Million | 4.33 Million | 4.41 Million | 4.32 Million | 4.32 Million |
| Income Tax Expense | 105.83 Million | 187.82 Million | 185.83 Million | 168.71 Million | -379.7 Million |
| Earnings before Tax | 494.41 Million | 589.35 Million | 589.43 Million | 532.96 Million | - |
| Net Income | 388.58 Million | 401.53 Million | 403.59 Million | 364.25 Million | 379.7 Million |
| Earnings Per Share Basic | 97.91 | 101.01 | 101.53 | 91.63 | 95.52 |
| Earnings Per Share Diluted | 97.91 | 101.01 | 101.53 | 91.63 | 95.52 |
| Weighted Average Shares Outstanding | 3.96 Million | 3.97 Million | 3.97 Million | 3.97 Million | 3.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.96 Million | 3.97 Million | 3.97 Million | 3.97 Million | 3.97 Million |
| Gross Margin | 0.23 | 0.24 | 0.22 | 0.19 | - |
| EBIT Margin | 0.09 | 0.11 | 0.12 | 0.11 | - |
| Profit Margin | 0.07 | 0.07 | 0.08 | 0.07 | - |
| EBITDA | 520.46 Million | 617.72 Million | 617.02 Million | 556.22 Million | 578.4 Million |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.09 | 0.05 | - |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.45 Billion | 1.38 Billion | 5.66 Billion | 1.46 Billion | 1.39 Billion | 1.41 Billion |
| Cost of Revenue | 1.11 Billion | 1.1 Billion | 4.36 Billion | 1.08 Billion | 1.08 Billion | 1.08 Billion |
| Gross Profit | 344.84 Million | 274.08 Million | 1.29 Billion | 376.71 Million | 310.47 Million | 333.03 Million |
| Operating Expenses | 202.57 Million | 175.87 Million | 740.12 Million | 178.3 Million | 181.58 Million | 204.37 Million |
| Selling, General and Administrative Expenses | 202.57 Million | 30.69 Million | - | 29.66 Million | 25.37 Million | 45.81 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -541 Thousand | 621 Thousand | 304 Thousand | 204 Thousand | 654 Thousand |
| Cost and Expenses | 1.31 Billion | 1.28 Billion | 5.1 Billion | 1.26 Billion | 1.27 Billion | 1.28 Billion |
| Operating Income | 142.26 Million | 98.21 Million | 554.17 Million | 198.41 Million | 128.89 Million | 128.65 Million |
| Interest Expense | 1.17 Million | 994 Thousand | 3.94 Million | 994 Thousand | 976 Thousand | 981 Thousand |
| Income Tax Expense | 44.33 Million | 43.33 Million | 105.83 Million | 30.19 Million | -8.56 Million | 40.86 Million |
| Earnings before Tax | 141.28 Million | 96.07 Million | 494.41 Million | 141.82 Million | 128.13 Million | 128.38 Million |
| Net Income | 96.95 Million | 52.74 Million | 388.58 Million | 111.63 Million | 136.7 Million | 87.51 Million |
| Earnings Per Share Basic | 24.67 | 13.29 | - | 28.08 | 34.39 | 22.01 |
| Earnings Per Share Diluted | 24.67 | 13.29 | - | 28.08 | 34.39 | 22.01 |
| Weighted Average Shares Outstanding | 3.93 Million | 3.96 Million | 3.96 Million | 3.97 Million | 3.97 Million | 3.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.93 Million | 3.96 Million | 3.96 Million | 3.97 Million | 3.97 Million | 3.97 Million |
| Gross Margin | 0.24 | 0.20 | 0.23 | 0.26 | 0.22 | 0.24 |
| EBIT Margin | 0.10 | 0.07 | - | 0.10 | 0.09 | 0.09 |
| Profit Margin | 0.07 | 0.04 | 0.07 | 0.08 | 0.10 | 0.06 |
| EBITDA | 147.86 Million | 100.67 Million | - | 145.63 Million | 132.13 Million | 132.32 Million |
| Earnings Before Tax Margin | 0.10 | 0.07 | 0.10 | 0.14 | 0.09 | 0.09 |
HPURF
3219
8464
HEMO
FFB
FMCCT